Could liposomes be the unsung heroes of the pandemic?

Berkeley engineers use liposomes to create new SARS-CoV-2 mimics which, when paired with a new DNA-patterning technique, could enable safe development of new COVID-19 diagnostic platforms and efficient testing of antibody therapies

Click to view original post